Apollo Global Management, Inc.
No SEC Form 4 filings for $APO in the last 30 days.
Indian equities fell on May 26 after reports of fresh US defensive strikes in southern Iran. The Nifty closed at 23,913.7 (-118 points, -0.49%) and the Sensex at 76,009.7 (-479.26 points, -0.63%). Analysts cited 24,000 resistance and 23,850 support. Trent, TCS, Bajaj Finance and Bharti Airtel led declines; Adani Ports and Tech Mahindra rose.
Fed Governor Christopher Waller said inflation risks mean the Fed should not signal rate cuts and may need to keep rates steady, with hikes possible if inflation persists. Julius Baer shares fell on slower client money inflows. Apollo’s $2.04 billion takeover proposal for Bodycote lifted shares. House Republicans opened an insider-trading probe into Kalshi and Polymarket.
Health Canada approved two generic semaglutide (Ozempic) products for Type 2 diabetes, expected to reach Alberta pharmacies “any day,” according to Apotex and a Vital spokesperson. Pharmacists said Ozempic costs about $280–$500 monthly, while Health Canada says generics are 45–90% cheaper; Apotex claims one-third the brand price. Alberta is reviewing submissions for provincial coverage.
